Company Filing History:
Years Active: 2024-2025
Title: Saikat Banerjee: Innovator in Immune Cell Therapy
Introduction
Saikat Banerjee is a prominent inventor based in Oakland, CA, specializing in advancements in cell therapy. He has made significant contributions to the field, particularly in improving immune cell functionality. With a total of 2 patents to his name, Banerjee is recognized for his innovative approaches to cancer treatment.
Latest Patents
Banerjee's latest patents focus on enhancing immune cell function. One of his notable inventions involves a membrane-bound interleukin 15 (IL-15)-IL-15Ralpha sushi domain chimeric receptor. This chimeric receptor aims to improve CAR and/or TCR function through enhanced cytokine signaling. Additionally, he has developed methods for treating cancer by engineering T cells to inhibit the endogenous expression of Blimp-1 and A20 while overexpressing TCF7 and Bach2. These methods aim to increase the peak fold proliferation rate, killing efficiency, and induce cellular characteristics associated with a naïve phenotype of immune cells.
Career Highlights
Saikat Banerjee is currently associated with Kite Pharma, Inc., where he continues to push the boundaries of cancer therapy through innovative research. His work has garnered attention in the scientific community, contributing to the advancement of cell therapy techniques.
Collaborations
Banerjee collaborates with esteemed colleagues, including Christopher Ecker and Yoonjung Shin, to further enhance the efficacy of immune cell therapies. Their combined expertise fosters a collaborative environment that drives innovation in the field.
Conclusion
Saikat Banerjee's contributions to immune cell therapy exemplify the potential of innovative research in transforming cancer treatment. His patents and ongoing work at Kite Pharma, Inc. highlight his commitment to improving patient outcomes through advanced therapeutic techniques.